IBDEI13J ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19344,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,19344,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,19345,0)
 ;;=788.7^^105^1230^54
 ;;^UTILITY(U,$J,358.3,19345,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19345,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,19345,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,19345,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,19346,0)
 ;;=131.02^^105^1230^57
 ;;^UTILITY(U,$J,358.3,19346,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19346,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,19346,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,19346,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,19347,0)
 ;;=597.80^^105^1230^55
 ;;^UTILITY(U,$J,358.3,19347,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19347,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,19347,1,5,0)
 ;;=5^Urethritis NOS
 ;;^UTILITY(U,$J,358.3,19347,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,19348,0)
 ;;=788.41^^105^1230^58
 ;;^UTILITY(U,$J,358.3,19348,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19348,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,19348,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,19348,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,19349,0)
 ;;=788.31^^105^1230^62
 ;;^UTILITY(U,$J,358.3,19349,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19349,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,19349,1,5,0)
 ;;=5^Urinary Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,19349,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,19350,0)
 ;;=788.20^^105^1230^63
 ;;^UTILITY(U,$J,358.3,19350,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19350,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,19350,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,19350,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,19351,0)
 ;;=112.2^^105^1230^66
 ;;^UTILITY(U,$J,358.3,19351,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19351,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,19351,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,19351,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,19352,0)
 ;;=600.01^^105^1230^5
 ;;^UTILITY(U,$J,358.3,19352,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19352,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,19352,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,19352,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,19353,0)
 ;;=600.10^^105^1230^40
 ;;^UTILITY(U,$J,358.3,19353,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19353,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,19353,1,5,0)
 ;;=5^Nod Prostate W/O UR Obst
 ;;^UTILITY(U,$J,358.3,19353,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,19354,0)
 ;;=585.9^^105^1230^8
 ;;^UTILITY(U,$J,358.3,19354,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19354,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,19354,1,5,0)
 ;;=5^Chronic Renal Failure
 ;;^UTILITY(U,$J,358.3,19354,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,19355,0)
 ;;=788.64^^105^1230^59
 ;;^UTILITY(U,$J,358.3,19355,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19355,1,4,0)
 ;;=4^788.64
 ;;^UTILITY(U,$J,358.3,19355,1,5,0)
 ;;=5^Urinary Hesitancy
 ;;^UTILITY(U,$J,358.3,19355,2)
 ;;=^334165
 ;;^UTILITY(U,$J,358.3,19356,0)
 ;;=788.65^^105^1230^52
 ;;^UTILITY(U,$J,358.3,19356,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19356,1,4,0)
 ;;=4^788.65
 ;;^UTILITY(U,$J,358.3,19356,1,5,0)
 ;;=5^Straining of Urination
 ;;^UTILITY(U,$J,358.3,19356,2)
 ;;=^334166
 ;;^UTILITY(U,$J,358.3,19357,0)
 ;;=600.00^^105^1230^4
 ;;^UTILITY(U,$J,358.3,19357,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19357,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,19357,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,19357,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,19358,0)
 ;;=599.70^^105^1230^20
 ;;
 ;;$END ROU IBDEI13J
